Complete Up To Date Information about Biosol Sterile Solution 50 mg.
NADA Number: 011-953 | |
| Proprietary Name |
Biosol® Sterile Solution 50 mg Biosol® Sterile Solution |
|---|---|
| Sponsor |
Pharmacia & Upjohn Co. |
| Sponsor Address |
a Division of Pfizer, Inc. 235 East 42nd St. New York, NY 10017 USA |
| Ingredients |
Neomycin Sulfate |
| Species |
Cat, no use class stated or implied Dog, no use class stated or implied |
| Routes of Administration |
Intravenous Intramuscular |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
522.1484 Neomycin sulfate sterile solution. Specifications: Each milliliter of sterile aqueous solution contains 50 milligrams of neomycin sulfate (equivalent to 35 milligrams of neomycin base). Conditions of use: Dogs Amount: 5 milligrams per pound of body weight daily divided into portions administered every 6 to 8 hours for 3 to 5 days. For intramuscular or intravenous use. Indications: Administer to dogs for the treatment of acute and chronic bacterial infections due to organisms susceptible to neomycin. Limitations: Neomycin is not for use parenterally in food-producing animals because of prolonged residues in edible tissues. Labeling shall bear an appropriate expiration date. For use by or on the order of a licensed veterinarian. Cats Amount: 5 milligrams per pound of body weight daily divided into portions administered every 6 to 8 hours for 3 to 5 days. For intramuscular or intravenous use. Indications: Administer to cats for the treatment of acute and chronic bacterial infections due to organisms susceptible to neomycin. Limitations: Neomycin is not for use parenterally in food-producing animals because of prolonged residues in edible tissues. Labeling shall bear an appropriate expiration date. For use by or on the order of a licensed veterinarian. NAS/NRC status: These claims are NAS/NRC reviewed and deemed effective. Applications for these uses need not include effectiveness data as specified by 514.111 of this chapter. |
| Tolerances |
Tolerances are established for residues of parent neomycin in uncooked edible tissues as follows: a. In cattle, swine, sheep, and goats: 7.2 parts per million in kidney (target tissue) and fat, 3.6 ppm in liver, and 1.2 ppm in muscle. b. In turkeys: 7.2 ppm in skin with adhering fat, 3.6 parts per million in liver, and 1.2 ppm in muscle. c. In milk: 0.15 part per million. |